Medication Overuse Headache clinical trials

Explore recruiting medication overuse headache clinical trials.

Recruiting medication overuse headache studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Medication Overuse Headache trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Interventional, randomized, double-blind, parallel-group, placebo-controlled study of add-on eptinezumab treatment to brief education intervention, for the preventive treatment of migraine in patients with a dual diagnosis of migraine and Medication Overuse Headache.

Netherlands, Norway, Germany, Italy, Spain, Denmark +2 more

Therapeutic use (Phase IV) EU CTIS Study details

Medication Overuse Headache trials by city

Medication Overuse Headache in Toronto Medication Overuse Headache in Vancouver Medication Overuse Headache in Montreal Medication Overuse Headache in Calgary Medication Overuse Headache in Edmonton Medication Overuse Headache in Ottawa Medication Overuse Headache in Winnipeg Medication Overuse Headache in Quebec City Medication Overuse Headache in Hamilton Medication Overuse Headache in Kitchener Medication Overuse Headache in London Medication Overuse Headache in Halifax Medication Overuse Headache in New York Medication Overuse Headache in Los Angeles Medication Overuse Headache in Chicago Medication Overuse Headache in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease